Document:

NAME
      OF SUBSCRIBER:_______________________               SUBSCRIPTION
      AMOUNT: $________________

     

    
      	
              To:
                

            	
              Derycz
                Scientific, Inc.

            
	 	
              10990
                Wilshire Blvd., Suite 1410

            
	 	
              Los
                Angeles, CA 90024

            
	 	
              Attn:  Mr.
                Peter Derycz

            
	 	
                         President

            

    

    

    SUBSCRIPTION
      AGREEMENT

     

    This
      Subscription Agreement (this “Agreement”) is being delivered to you in
      connection with your investment in Derycz Scientific, Inc. (the “Company”) as
      part of a private placement (the “Offering”) of Securities, consisting of 1
      share of common stock of the Company (the “Shares”) and, for every 2 shares
      purchased, a Warrant to purchase 1 share of common stock of the Company (the
      “Warrants”, the Shares and Warrants are collectively referred to as the
“Securities”), at a purchase price of $2.00 per
      share. 

     

    1. Subscription
      and Purchase Price

     

    (a) Subscription.
      Subject
      to the conditions set forth in Section 2 hereof, the undersigned hereby
      subscribes for and agrees to purchase the number of Shares and Warrants
      indicated on page 8 hereof on the terms and conditions described herein. The
      minimum amount of Shares and Warrants that may be purchased is $50,000.
      Subscriptions for lesser amounts may be accepted at the discretion of the
      Company.

     

    (b) Purchase
      of Securities.
      The
      undersigned understands and acknowledges that the purchase price to be remitted
      to the Company in exchange for the Securities shall be $1.50 per Share, for
      an
      aggregate purchase price as set forth on page 8 hereof (the “Aggregate Purchase
      Price”). The undersigned’s delivery of this Agreement to the Company shall be
      accompanied by payment for the Securities subscribed for hereunder, payable
      in
      United States dollars, by check made payable to the order of “Derycz
      Scientific, Inc.”
or
      by
      wire transfer of immediately available funds delivered contemporaneously with
      the undersigned’s delivery of this Agreement to the Company. The undersigned
      understands and agrees that, subject to Section 2 and applicable laws, by
      executing this Agreement, he, she or it is entering into a binding agreement.
      

     

    2. Acceptance
      and Closing Procedures

     

    (a) Acceptance
      or Rejection.
      The
      obligation of the undersigned to purchase the Securities shall be irrevocable,
      and the undersigned shall be legally bound to purchase the Securities subject
      to
      the terms set forth in this Agreement. The undersigned understands and agrees
      that the Company reserves the right to reject this subscription for the
      Securities in whole or part in any order at any time prior to the closing (the
      “Closing”) of the purchase and sale of the Securities if, in its reasonable
      judgment, it deems such action to be in the best interest of the Company,
      notwithstanding the undersigned’s prior receipt of notice of acceptance of the
      undersigned’s subscription. In the event of rejection of this subscription by
      the Company in accordance with this Section 2, or the sale of the Securities
      is
      not consummated by the Company for any reason, this Agreement and any other
      agreement entered into between the undersigned and the Company relating to
      this
      subscription shall thereafter have no force or effect, and the Company shall
      promptly return or cause to be returned to the undersigned the purchase price
      remitted to the Company, without interest thereon or deduction
      therefrom.

     

    (b) Closing.
      Each
      Closing shall take place at such times as determined by the Company (each
      closing date referred to as a “Closing Date”), or such other date as is mutually
      agreed to by the Company and the undersigned. The Common Stock and the Warrants
      purchased by the Subscriber will be delivered by the Company promptly following
      a Closing.

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

     

    3. Investor’s
      Representations and Warranties

     

    The
      undersigned hereby acknowledges, agrees with and represents and warrants to
      the
      Company, as follows:

     

    (a) The
      undersigned has full power and authority to enter into this Agreement, the
      execution and delivery of which has been duly authorized, if applicable, and
      this Agreement constitutes a valid and legally binding obligation of the
      undersigned.

     

    (b) The
      undersigned acknowledges his, her or its understanding that the offering and
      sale of the Common Stock, the Warrants and the common stock issuable upon
      exercise of the Warrants are intended to be exempt from registration under
      the
      Securities Act of 1933, as amended (the “Securities Act”), by virtue of Section
      4(2) of the Securities Act and the provisions of Regulation D promulgated
      thereunder (“Regulation D”). In furtherance thereof, the undersigned represents
      and warrants to the Company as follows:

     

    (i) The
      undersigned realizes that the basis for the exemption from registration may
      not
      be available if, notwithstanding the undersigned’s representations contained
      herein, the undersigned is merely acquiring the Securities for a fixed or
      determinable period in the future, or for a market rise, or for sale if the
      market does not rise. The undersigned does not have any such
      intention.

     

    (ii) The
      undersigned is acquiring the Securities solely for the undersigned’s own
      beneficial account, for investment purposes, and not with a view to, or resale
      in connection with, any distribution of the Securities.

     

    (iii) The
      undersigned has the financial ability to bear the economic risk of his, her
      or
      its investment, has adequate means for providing for their current needs and
      contingencies, and has no need for liquidity with respect to the investment
      in
      the Company;

     

    (iv) The
      undersigned (together with the undersigned’s attorney, accountant, purchaser
      representative and/or tax advisor, if any (collectively, “Advisors”), has such
      knowledge and experience in financial and business matters as to be capable
      of
      evaluating the merits and risks of the prospective investment in the Securities.
      If other than an individual, the undersigned also represents it has not been
      organized solely for the purpose of acquiring the Shares.

     

    (c) The
      information in the Investor Questionnaire completed and executed by the
      undersigned (the “Investor Questionnaire”) is true and accurate in all respects,
      and the undersigned is an “accredited investor,” as that term is defined in Rule
      501(a) of Regulation D.

     

    (d) The
      undersigned is not relying on the Company or its affiliates or sub-agents with
      respect to economic considerations involved in this investment. The undersigned
      has relied on the advice of, or has consulted with, only his, her or its
      Advisors. Each Advisor, if any, is capable of evaluating the merits and risks
      of
      an investment in the Securities and each Advisor, if any, has disclosed to
      the
      undersigned in writing (a copy of which is annexed to this Agreement) the
      specific details of any and all past, present or future relationships, actual
      or
      contemplated, between the Advisor and the Company or any affiliate or sub-agent
      thereof.

     

    (e) The
      undersigned represents, warrants and agrees that he, she or it will not sell
      or
      otherwise transfer the Securities without registration under the Securities
      Act
      or an exemption therefrom, and fully understands and agrees that the undersigned
      must bear the economic risk of his, her or its purchase because, among other
      reasons, the Securities have not been registered under the Securities Act or
      under the securities laws of any state and, therefore, cannot be resold,
      pledged, assigned or otherwise disposed of unless they are subsequently
      registered under the Securities Act and under the applicable securities laws
      of
      such states, or an exemption from such registration is available. In particular,
      the undersigned is aware that the Securities are “restricted securities,” as
      such term is defined in Rule 144 promulgated under the Securities Act (“Rule
      144”), and they may not be sold pursuant to Rule 144 unless all of the
      conditions of Rule 144 are met. The undersigned also understands that, except
      as
      otherwise provided in Section 5 hereof, the Company is under no obligation
      to
      register the Securities on his, her or its behalf or to assist the undersigned
      in complying with any exemption from registration under the Securities Act
      or
      applicable state securities laws. The undersigned understands that any sales
      or
      transfers of the Securities are further restricted by state securities laws
      and
      the provisions of this Agreement.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    (f) No
      representations or warranties have been made to the undersigned by the Company
      or its officers, employees, agents, sub-agents, affiliates or subsidiaries,
      other than any representations of the Company contained herein, and in
      subscribing for the Securities the undersigned is not relying upon any
      representations other than those contained herein.

     

    (g) The
      undersigned understands and acknowledges that his, her or its purchase of the
      Securities is a speculative investment that involves a high degree of risk
      and
      the potential loss of the undersigned’s entire investment and, in particular,
      acknowledges that the Company has a limited operating history and is engaged
      in
      a highly competitive business. 

     

    (h) The
      undersigned’s overall commitment to investments that are not readily marketable
      is not disproportionate to the undersigned’s net worth, and an investment in the
      Securities will not cause such overall commitment to become
      excessive.

     

    (i) The
      undersigned understands and agrees that the certificates for the Securities
      shall bear substantially the following legend until (i) such Securities shall
      have been registered under the Securities Act and effectively disposed of in
      accordance with a registration statement that has been declared effective or
      (ii) in the opinion of counsel for the Company such Securities may be sold
      without registration under the Securities Act, as well as any applicable “blue
      sky” or state securities laws:

     

    THE
      SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY APPLICABLE
      STATE SECURITIES LAWS. SUCH SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT
      PURPOSES AND MAY NOT BE OFFERED FOR SALE, SOLD, DELIVERED AFTER SALE,
      TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
      STATEMENT FILED BY THE ISSUER WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION
      COVERING SUCH SECURITIES UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL
      SATISFACTORY TO THE ISSUER THAT SUCH REGISTRATION IS NOT REQUIRED.

     

    (j) Neither
      the U.S. Securities and Exchange Commission (the “SEC”) nor any state securities
      commission has approved the Securities or passed upon or endorsed the merits
      of
      the Offering

     

    (k) The
      undersigned and his, her or its Advisors, if any, have had a reasonable
      opportunity to ask questions of and receive answers from a person or persons
      acting on behalf of the Company concerning the offering of the Securities and
      the business, financial condition, results of operations and prospects of the
      Company, and all such questions have been answered to the full satisfaction
      of
      the undersigned and his, her or its Advisors, if any.

     

    (l) The
      undersigned is unaware of, is in no way relying on, and did not become aware
      of
      the offering of the Securities through or as a result of, any form of general
      solicitation or general advertising including, without limitation, any article,
      notice, advertisement or other communication published in any newspaper,
      magazine or similar media or broadcast over television or radio, or electronic
      mail over the Internet, in connection with the offering and sale of the
      Securities and is not subscribing for the Securities and did not become aware
      of
      the offering of the Securities through or as a result of any seminar or meeting
      to which the undersigned was invited by, or any solicitation of a subscription
      by, a person not previously known to the undersigned in connection with
      investments in securities generally.

     

    (m) The
      undersigned has taken no action which would give rise to any claim by any person
      for brokerage commissions, finders’ fees or the like relating to this Agreement
      or the transactions contemplated hereby.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    (n) The
      undersigned is not relying on the Company, or any of its employees, agents
      or
      sub-agents with respect to the legal, tax, economic and related considerations
      of an investment in the Securities, and the undersigned has relied on the advice
      of, or has consulted with, only his, her or its own Advisors. 

     

    (o) The
      undersigned acknowledges that any estimates or forward-looking statements or
      projections included in the Public Filings (as defined in Section 4(d)) were
      prepared by the management of the Company in good faith, but that the attainment
      of any such projections, estimates or forward-looking statements cannot be
      guaranteed by the Company or its management and should not be relied
      upon.

     

    (p) No
      oral
      or written representations have been made, or oral or written information
      furnished, to the undersigned or his, her or its Advisors, if any, in connection
      with the offering of the Securities which are in any way inconsistent with
      the
      information contained in the Public Filings.

     

    (q) 
      (For
      ERISA plans only) The fiduciary of the ERISA plan (the “Plan”) represents that
      such fiduciary has been informed of and understands the Company’s investment
      objectives, policies and strategies, and that the decision to invest “plan
      assets” (as such term is defined in ERISA) in the Company is consistent with the
      provisions of ERISA that require diversification of plan assets and impose
      other
      fiduciary responsibilities. The Subscriber or Plan fiduciary (a) is responsible
      for the decision to invest in the Company; (b) is independent of the Company
      and
      any of its affiliates; (c) is qualified to make such investment decision; and
      (d) in making such decision has not relied primarily on any advice or
      recommendation of the Company or any of its affiliates.

     

    (r) The
      foregoing representations, warranties and agreements shall survive the
      Closing.

     

    4. The
      Company’s Representations, Warranties and Covenants

     

    The
      Company hereby acknowledges, agrees with and represents, warrants and covenants
      to each of the undersigned, as follows:

     

    (a) The
      Company has the corporate power and authority to execute and deliver this
      Agreement and to perform its obligations hereunder. This Agreement has been
      duly
      authorized, executed and delivered by the Company and is valid, binding and
      enforceable against the Company in accordance with its terms. 

     

    (b) The
      Securities to be issued to the undersigned pursuant to this Agreement, when
      issued and delivered in accordance with the terms of this Agreement, will be
      duly and validly issued and will be fully paid and non-assessable. 

     

    (c) Neither
      the execution and delivery nor the performance of this Agreement by the Company
      will conflict with the Company’s Certificate of Incorporation or By-laws, as
      amended to date, or result in a breach of any terms or provisions of, or
      constitute a default under, any material contract, agreement or instrument
      to
      which the Company is a party or by which the Company is bound.

     

    (d) The
      Company is a reporting company pursuant to Section 15(d) of the Securities
      Exchange Act of 1934, as amended (the “Exchange
      Act”),
      and
      the Company has timely filed all reports, schedules, forms, statements and
      other
      documents required to be filed by it with the SEC pursuant to the reporting
      requirements of the Exchange Act. At the times of their respective filings,
      the
      Form S-1/A filed on March 21, 2008 (the “Form S-1/A”) and the Form 10-Q for the
      fiscal quarter ended March 31, 2008 (the “Form
      10-Q”
and
      together with the Form S-1/A any other report, schedule, form, statement or
      other document filed by the Company with the SEC pursuant to the reporting
      requirements of the Exchange Act subsequent to the filing of the Form 10-Q
      and
      prior to the date of this Agreement, the “Public
      Filings”)
      complied in all material respects with the requirements of the Securities Act
      or
      Exchange Act, as applicable, and the rules and regulations of the SEC
      promulgated thereunder, and the Public Filings did not contain any untrue
      statement of a material fact or omit to state a material fact required to be
      stated therein or necessary in order to make the statements therein, in light
      of
      the circumstances under which they were made, not misleading. As of their
      respective dates, the financial statements of the Company included in the Public
      Filings complied as to form in all material respects with applicable accounting
      requirements and the published rules and regulations of the SEC or other
      applicable rules and regulations with respect thereto. Such financial statements
      have been prepared in accordance with generally accepted accounting principles
      (“GAAP”)
      applied on a consistent basis during the periods involved (except (i) as may
      be
      otherwise indicated in such financial statements or the notes thereto or (ii)
      in
      the case of unaudited interim statements, to the extent they may not include
      footnotes or may be condensed or summary statements), and fairly present in
      all
      material respects the financial position of the Company and its subsidiaries
      as
      of the dates thereof and the results of operations and cash flows for the
      periods then ended (subject, in the case of unaudited statements, to normal
      year-end audit adjustments). 

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    (e) The
      Company will remain a reporting company pursuant to the Exchange Act for a
      period of not less than one year from the date of this Agreement.

     

    5. Registration
      Rights 

     

    If
      at any
      time after the date hereof the Company shall file a registration statement
      (other than on Form S-4 or S-8, or any then equivalent thereof), the Company
      shall include the Shares and shall maintain, so long as any other shares of
      common stock shall be so registered, such registration of the Shares. In the
      event of such registration, the Company shall list the Shares on each national
      securities exchange or automated quotation system, as the case may be, on which
      the Company’s common stock is listed and shall maintain such listing if and so
      long as any shares of the same class shall be listed on such national securities
      exchange or automated quotation system.

    

    6. Indemnity

     

    The
      undersigned agrees to indemnify and hold harmless the Company and its officers
      and directors, employees, agents, sub-agents and affiliates and each other
      person, if any, who controls any of the foregoing, against any loss, liability,
      claim, damage and expense whatsoever (including, but not limited to, any and
      all
      expenses whatsoever reasonably incurred in investigating, preparing or defending
      against any litigation commenced or threatened or any claim whatsoever) arising
      out of or based upon any false representation or warranty by the undersigned,
      or
      the undersigned’s breach of, or failure to comply with, any covenant or
      agreement made by the undersigned herein or in any other document furnished
      by
      the undersigned to the Company and its officers and directors, employees,
      agents, sub-agents and affiliates and each other person, if any, who controls
      any of the foregoing in connection with the Offering.

     

    7. Conditions
      to Acceptance of Subscription

     

    The
      Company’s right to accept the subscription of the undersigned is conditioned
      upon satisfaction of the following conditions precedent on or before the date
      the Company accepts such subscription (any or all of which may be waived by
      the
      undersigned in his, her or its sole discretion):

     

    (a) On
      the
      Closing Date, no legal action, suit or proceeding shall be pending which seeks
      to restrain or prohibit the transactions contemplated by this
      Agreement.

     

    (b) The
      representations and warranties of the Company contained in this Agreement shall
      have been true and correct on the date of this Agreement and shall be true
      and
      correct on the Closing Date as if made on the Closing Date.

     

    8. Notices
      to Subscribers

     

    (a) THE
      SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES
      LAWS OF ANY STATE AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS
      FROM
      THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND SUCH LAWS. THE
      SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SEC, ANY STATE
      SECURITIES COMMISSION OR OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF THE
      FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR
      THE
      ACCURACY OR ADEQUACY OF THE MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY
      IS
      UNLAWFUL.

     

    (b) THE
      SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY
      NOT
      BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT, AND
      APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION
      THEREFROM. SUBSCRIBERS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE
      FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF
      TIME.

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    

    
      
        9.
          Miscellaneous
          Provisions

      

    

     

    (a) Modification.
      Neither
      this Agreement, nor any provisions hereof, shall be waived, modified, discharged
      or terminated except by an instrument in writing signed by the party against
      whom any waiver, modification, discharge or termination is sought.

     

    (b) Survival.
      The
      undersigned’s representations and warranties made in this Agreement shall
      survive the execution and delivery of this Agreement and the delivery of the
      Securities.

     

    (c) Notices.
      Any
      party may send any notice, request, demand, claim or other communication
      hereunder to the undersigned at the address set forth on the signature page
      of
      this Agreement or to the Company at the address set forth above using any means
      (including personal delivery, expedited courier, messenger service, fax,
      ordinary mail or electronic mail), but no such notice, request, demand, claim
      or
      other communication will be deemed to have been duly given unless and until
      it
      actually is received by the intended recipient. Any party may change the address
      to which notices, requests, demands, claims and other communications hereunder
      are to be delivered by giving the other parties written notice in the manner
      herein set forth.

     

    (d) Binding
      Effect.
      Except
      as otherwise provided herein, this Agreement shall be binding upon, and inure
      to
      the benefit of, the parties to this Agreement and their heirs, executors,
      administrators, successors, legal representatives and assigns. If the
      undersigned is more than one person or entity, the obligation of the undersigned
      shall be joint and several and the agreements, representations, warranties
      and
      acknowledgments contained herein shall be deemed to be made by, and be binding
      upon, each such person or entity and his or its heirs, executors,
      administrators, successors, legal representatives and assigns. This Agreement
      sets forth the entire agreement and understanding between the parties as to
      the
      subject matter thereof and merges and supersedes all prior discussions,
      agreements and understandings of any and every nature among them.

     

    (e) Assignability.
      This
      Agreement is not transferable or assignable by the undersigned. This Agreement
      shall be transferable or assignable by the Company to a proposed publicly-traded
      successor company.

     

    (f) Governing
      Law.
      This
      Agreement shall be governed by and construed in accordance with the laws of
      the
      State of California, without giving effect to conflicts of law
      principles.

     

    (g) Counterparts.
      This
      Agreement may be executed in two or more counterparts, each of which shall
      be
      deemed an original, but all of which together shall constitute one and the
      same
      instrument.

     

    10. U.S.A.
      Patriot Act Representations.

     

    (a) Subscriber
      represents, warrants and covenants that Subscriber: 

     

    (i)(a)
      is
      subscribing for the Securities for Subscriber’s own account, own risk and own
      beneficial interest, (b) is not acting as an agent, representative,
      intermediary, nominee or in a similar capacity for any other person or entity,
      nominee account or beneficial owner, whether a natural person or entity (each
      such natural person or entity, an “Underlying Beneficial Owner”) and no
      Underlying Beneficial Owner will have a beneficial or economic interest in
      the
      Securities being purchased by Subscriber (whether directly or indirectly,
      including without limitation, through any option, swap, forward or any other
      hedging or derivative transaction), (c) if it is an entity, including, without
      limitation, a fund-of-funds, trust, pension plan or any other entity that is
      not
      a natural person (each, an “Entity”), has carried out thorough due diligence as
      to and established the identities of such Entity’s investors, directors,
      officers, trustees, beneficiaries and grantors (to the extent applicable, each
      a
“Related Person” of such Entity), holds the evidence of such identities, will
      maintain all such evidence for at least five years from the date of Subscriber’s
      resale or other disposition of all the Common Stock underlying the Securities
      and Warrants, will request such additional information as the Company may
      require to verify such identities as may be required by applicable law, and
      will
      make such information available to the Company upon its request, and (d) does
      not have the intention or obligation to sell, pledge, distribute, assign or
      transfer all or a portion of the Common Stock and Warrants to any Underlying
      Beneficial Owner or any other person; or

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

    

    (ii)(a)
      is subscribing for the Securities as a record owner and will not have a
      beneficial ownership interest in the Securities, (b) is acting as an agent,
      representative, intermediary, nominee or in a similar capacity for one or more
      Underlying Beneficial Owners (as defined in (A)(i)(a) above), and understands
      and acknowledges that the representations, warranties and agreements made in
      this Agreement are made by Subscriber with respect to both Subscriber and the
      Underlying Beneficial Owner(s), (c) has all requisite power and authority from
      the Underlying Beneficial Owner(s) to execute and perform the obligations under
      the Subscription Agreement, (d) has carried out thorough due diligence as to
      and
      established the identities of all Underlying Beneficial Owners (and, if an
      Underlying Beneficial Owner is not a natural person, the identities of such
      Underlying Beneficial Owner’s Related Persons (to the extent applicable)), holds
      the evidence of such identities, will maintain all such evidence for at least
      five years from the date of Subscriber’s resale or other disposition of all the
      Common Stock and Warrants, and will make such information available to the
      Company upon its request and (e) does not have the intention or obligation
      to
      sell, pledge, distribute, assign or transfer all or a portion of the Common
      Stock and Warrants to any person other than the Underlying Beneficial
      Owner(s).

    

    (b) Subscriber
      hereby represents and warrants that the proposed investment in the Company
      that
      is being made on its own behalf or, if applicable, on behalf of any Underlying
      Beneficial Owners does not directly or indirectly contravene United States
      federal, state, local or international laws or regulations applicable to
      Subscriber, including anti-money laundering laws (a “Prohibited
      Investment”).

    

    (c) Federal
      regulations and Executive Orders administered by the U.S. Treasury Department’s
      Office of Foreign Assets Control (“OFAC”) prohibit, among other things, the
      engagement in transactions with, and the provision of services to, certain
      foreign countries, territories, entities and individuals. The lists of OFAC
      prohibited countries, territories, persons and entities can be found on the
      OFAC
      website at www.treas.gov/ofac. Subscriber hereby represents and warrants that
      neither Subscriber nor, if applicable, any Underlying Beneficial Owner or
      Related Person, is a country, territory, person or entity named on an OFAC
      list,
      nor is Subscriber nor, if applicable, any Underlying Beneficial Owner or Related
      Person, a natural person or entity with whom dealings are prohibited under
      any
      OFAC regulations. 

    

    (d) Subscriber
      represents and warrants that neither Subscriber nor, if applicable, any
      Underlying Beneficial Owner or Related Person, is a senior foreign political
      figure, or any immediate family member or close associate of a senior foreign
      political figure within the meaning of, and applicable guidance issued by the
      Department of the Treasury concerning, the U.S. Bank Secrecy Act (31 U.S.C.
      §5311 et seq.), as amended, and any regulations promulgated
      thereunder.

    

    (e) Subscriber
      agrees promptly to notify the Company should Subscriber become aware of any
      change in the information set forth in paragraphs (a) through (d). 

    

    (f) Subscriber
      agrees to indemnify and hold harmless the Company, its affiliates, and their
      respective directors, officers, shareholders, employees, agents and
      representatives (each, an “Indemnitee”) from and against any and all losses,
      liabilities, damages, penalties, costs, fees and expenses (including legal
      fees
      and disbursements) (collectively, “Damages”) which may result, directly or
      indirectly, from Subscriber’s misrepresentations or misstatements contained
      herein or breaches hereof relating to paragraphs (a) through (d).

    

    (g) Subscriber
      understands and agrees that, notwithstanding anything to the contrary contained
      in any document (including any side letters or similar agreements), if,
      following Subscriber’s investment in the Company, it is discovered that the
      investment is or has become a Prohibited Investment, such investment may
      immediately be redeemed by the Company or otherwise be subject to the remedies
      required by law, and Subscriber shall have no claim against any Indemnitee
      for
      any form of Damages as a result of such forced redemption or other
      action.

    

    (h) Upon
      the
      written request from the Company, Subscriber agrees to provide all information
      to the Company to enable the Company to comply with all applicable anti-money
      laundering statutes, rules, regulations and policies, including any policies
      applicable to a portfolio investment held or proposed to be held by the Company.
      Subscriber understands and agrees that the Company may release confidential
      information about Subscriber and, if applicable, any Underlying Beneficial
      Owner(s) or Related Person(s) to any person, if the Company, in its sole
      discretion, determines that such disclosure is necessary to comply with
      applicable statutes, rules, regulations and policies.

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

    

    ALL
      SUBSCRIBERS MUST COMPLETE THIS PAGE

     

    IN
      WITNESS WHEREOF, the undersigned has executed this Agreement on the ____ day
      of
      ____________ 2008.

    

    
      	
              ________________________

            	
              x
                $1.50 for each Share

            	
              =
                $_____________________.

            
	
              Shares
                subscribed for

            	 	
              Aggregate
                Purchase Price

            

    

    

    The
      number of Warrants issuable will be equal to the number of Shares subscribed
      for
      divided by 2, without giving effect to any fractional warrants.

    

    Manner
      in
      which Title is to be held (Please Check One):

     

    
      	
              1.

            	
              ___

            	
              Individual

            	
              7.

            	
              ___

            	
              Trust/Estate/Pension
                or Profit sharing Plan

              Date
                Opened:______________

            
	 	 	 	 	 	 
	
              2.

            	
              ___

            	
              Joint
                Tenants with Right of Survivorship

            	
              8.

            	
              ___

            	
              As
                a Custodian for

              ________________________________

              Under
                the Uniform Gift to Minors Act of the State of

              ________________________________

            
	 	 	 	 	 	 
	
              3.

            	
              ___

            	
              Community
                Property

            	
              9.

            	
              ___

            	
              Married
                with Separate Property

            
	 	 	 	 	 	 
	
              4.

            	
              ___

            	
              Tenants
                in Common

            	
              10.

            	
              ___

            	
              Keogh

            
	 	 	 	 	 	 
	
              5.

            	
              ___

            	
              Corporation/Partnership/
                Limited Liability Company

            	
              11.

            	
              ___

            	
              Tenants
                by the Entirety

               

            
	 	 	 	 	 	 
	
              6.

            	
              ___

            	
              IRA

            	 	 	 

    

     

    

    ALTERNATIVE
      DISTRIBUTION INFORMATION

     

    To
      direct
      distribution to a party other than the registered owner, complete the
      information below. YOU MUST COMPLETE THIS SECTION IF THIS IS AN IRA
      INVESTMENT.

     

    Name of Firm (Bank, Brokerage, Custodian): _______________________________________________________________________________________________________________

     

    Account Name: ____________________________________________________________________________________________________________________________________

     

    Account Number: ___________________________________________________________________________________________________________________________________

     

    Representative Name: ________________________________________________________________________________________________________________________________

     

    Representative Phone Number: _________________________________________________________________________________________________________________________

     

    Address: _________________________________________________________________________________________________________________________________________

     

    City, State, Zip: _____________________________________________________________________________________________________________________________________

     

    IF
      MORE
      THAN ONE SUBSCRIBER, EACH SUBSCRIBER MUST SIGN.

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

    EXECUTION
      BY NATURAL PERSONS

     

    _____________________________________________________________________________

    Exact
      Name in Which Title is to be Held

    

    
      	
              _________________________________

               Name
                (Please Print)

            	 	
              _________________________________

               Name
                of Additional Purchaser

            
	 	 	 
	
              _________________________________

               Residence:
                Number and Street

            	 	
              _________________________________

               Address
                of Additional Purchaser

            
	 	 	 
	
              _________________________________

               City,
                State and Zip Code

            	 	
              _________________________________

               City,
                State and Zip Code

            
	 	 	 
	
              _________________________________

               Social
                Security Number

            	 	
              _________________________________

               
                Social Security Number

            
	 	 	 
	
              _________________________________
                

              Telephone
                Number 

            	 	
              _________________________________

              Telephone
                Number

            
	 	 	 
	
              _________________________________
                

              Fax
                Number (if available)

            	 	
              ________________________________

              Fax
                Number (if available)

            
	 	 	 
	
              _________________________________
                

              E-Mail
                (if available) 

            	 	
              ________________________________
                

              E-Mail
                (if available)

            
	 	 	 
	
              __________________________________

               (Signature)

            	 	
              ________________________________

               (Signature
                of Additional Purchaser)

            

    

     

    ACCEPTED
      this ___ day of _________ 2008, on behalf of the Company.

    

    
      	
              By:

            	
              _________________________________

            
	 	
              Name:

            
	 	
              Title:

            

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    EXECUTION
      BY SUBSCRIBER WHICH IS AN ENTITY

    (Corporation,
      Partnership, LLC, Trust, Etc.)

    

    _____________________________________________________________________________

    Name
      of
      Entity (Please Print)

    

    Date of Incorporation or Organization: _______________________________________________________________________________________________________________

     

    State of Principal Office: __________________________________________________________________________________________________________________________

    

    Federal Taxpayer Identification Number: _______________________________________________________________________________________________________________

     

    ____________________________________________

    Office
      Address

    ____________________________________________

    City,
      State and Zip Code

    ____________________________________________

    Telephone
      Number

    ____________________________________________

    Fax
      Number (if available)

    ____________________________________________

    E-Mail
      (if available)

    

    
      	
              By:

            	
              _________________________________

            
	 	
              Name:

            
	 	
              Title:

            

    

     

    
      	
              [seal]

            	 
	
              Attest:
                _________________________________

            	_________________________________ 
	
                                             (If
                Entity is a Corporation)

            	 
	 	 
	 	
              _________________________________

            
	 	
              Address

            

    

    

    ACCEPTED
      this ____ day of __________ 2008, on behalf of the Company.

    

    
      	
              By:

            	
              _________________________________

            
	 	
              Name:

            
	 	
              Title:

            

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    INVESTOR
      QUESTIONNAIRE

     

    Instructions:
      Check all boxes below which correctly describe you.

     

    
      	o	
              You
                are (i)
                a
                bank, as defined in Section 3(a)(2) of the Securities Act of 1933,
                as
                amended (the “Securities
                Act”),
                (ii)
                a
                savings and loan association or other institution, as defined in
                Section
                3(a)(5)(A) of the Securities Act, whether acting in an individual
                or
                fiduciary capacity, (iii)
                a
                broker or dealer registered pursuant to Section 15 of the Securities
                Exchange Act of 1934, as amended (the “Exchange
                Act”),
                (iv)
                an insurance company as defined in Section 2(13) of the Securities
                Act,
                (v)
                an investment company registered under the Investment Company Act
                of 1940,
                as amended (the “Investment
                Company Act”),
                (vi)
                a
                business development company as defined in Section 2(a)(48) of the
                Investment Company Act, (vii)
                a
                Small Business Investment Company licensed by the U.S. Small Business
                Administration under Section 301 (c) or (d) of the Small Business
                Investment Act of 1958, as amended, (viii)
                a
                plan established and maintained by a state, its political subdivisions,
                or
                an agency or instrumentality of a state or its political subdivisions,
                for
                the benefit of its employees and you have total assets in excess
                of
                $5,000,000, or (ix)
                an employee benefit plan within the meaning of the Employee Retirement
                Income Security Act of 1974, as amended (“ERISA”)
                and (1)
                the decision that you shall subscribe for and purchase the Securities,
                is
                made by a plan fiduciary, as defined in Section 3(21) of ERISA, which
                is
                either a bank, savings and loan association, insurance company, or
                registered investment adviser, (2) you have total assets in excess
                of
                $5,000,000 and the decision that you shall subscribe for and purchase
                the
                Securities is made solely by persons or entities that are accredited
                investors, as defined in Rule 501 of Regulation D promulgated under
                the
                Securities Act (“Regulation
                D”)
                or (3)
                you are a self-directed plan and the decision that you shall subscribe
                for
                and purchase the Securities is made solely by persons or entities
                that are
                accredited investors.

            

    

     

    
      	o	
              You
                are a private business development company as defined in Section
                202(a)(22) of the Investment Advisers Act of 1940, as
                amended.

            

    

     

    
      	o	
              You
                are an organization described in Section 501(c)(3) of the Internal
                Revenue
                Code of 1986, as amended (the “Code”),
                a corporation, Massachusetts or similar business trust or a partnership,
                in each case not formed for the specific purpose of making an investment
                in the Securities and with total assets in excess of
                $5,000,000.

            

    

     

    
      	o	
              You
                are a director or executive officer of Reprints Desk, Inc. or Derycz
                Scientific, Inc.

            

    

     

    
      	o	
              You
                are a natural person whose individual net worth, or joint net worth
                with
                your spouse, exceeds $1,000,000 at the time of your subscription
                for and
                purchase of the Securities.

            

    

     

    
      	o	
              You
                are a natural person who had an individual income in excess of $200,000
                in
                each of the two most recent years or joint income with your spouse
                in
                excess of $300,000 in each of the two most recent years, and who
                has a
                reasonable expectation of reaching the same income level in the current
                year.

            

    

     

    
      	o	
              You
                are a trust, with total assets in excess of $5,000,000, not formed
                for the
                specific purpose of acquiring the Securities, whose subscription
                for and
                purchase of the Securities is directed by a sophisticated person
                as
                described in Rule 506(b)(2)(ii) of Regulation
                D.

            

    

     

    
      	o	
              You
                are an entity in which all of the equity owners are persons or entities
                described in one of the preceding
                paragraphs.

            

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    Check
      all boxes below which correctly describe you.

     

    With
      respect to this investment in Securities of the Company, your:

    

      
        	
                Investment
                  Objectives: 

              	
                x Aggressive
                  Growth 

              	
                x
                  Speculation

              	 
	 	 	 	 
	
                Risk
                  Tolerance:  

              	
                 ̈
                  Low Risk  

              	
                 ̈
                  Moderate Risk  

              	
                x
                  High Risk

              

      

    

     

    Are
      you
      associated with a NASD Member Firm?   o Yes 
       o No

     

    Your
      initials (purchaser and co-purchaser, if applicable) are required for each
      item
      below:

    

      
        	
                ____  
                  

              	
                ____  

              	
                I/We
                  understand that this investment is not guaranteed.

              
	 	 	 
	
                ____  
                  

              	
                ____  

              	
                I/We
                  are aware that this investment is not liquid.

              
	 	 	 
	
                ____  
                  

              	
                ____  

              	
                I/We
                  are sophisticated in financial and business affairs and are able
                  to
                  evaluate the risks and merits of an  investment in this
                  offering.

              
	 	 	 
	
                ____ 
                  

                 

              	
                ____  

                 

              	
                I/We
                  confirm that this investment is considered “high risk.” (This type of
                  investment is considered high risk due to the inherent risks including
                  lack of liquidity and lack of diversification.  Success or failure of
                  private placements such as this is dependent on the corporate issuer
                  of
                  these securities and is outside the control of the investors. While
                  potential loss is limited to the amount invested, such loss is
                  possible.)

              

      

    

     

    The
      undersigned hereby represents and warrants that all of its answers to this
      Investor Questionnaire are true as of the date of its execution of the
      Subscription Agreement pursuant to which it purchased Securities of the
      Company.

    

    
      	_______________________________ 	_______________________________ 
	
              Name
                of Purchaser [please print]

            	
              Name
                of Co-Purchaser [please print]

            
	 	 
	_______________________________ 	_______________________________ 
	
              Signature
                of Purchaser (Entities please

              provide
                signature of Purchaser’s duly

              authorized
                signatory.)

            	
              Signature
                of Co-Purchaser

            
	 	 
	_______________________________ 	 
	
              Name
                of Signatory (Entities only)

            	 
	 	 
	_______________________________ 	 
	
              Title
                of Signatory (Entities only)Unassociated Document

     

    Exhibit
      10.2

     

    EMPLOYMENT
      AGREEMENT

    BETWEEN
      DYNAMIC APPLICATIONS CORPORATION 

    AND

    AMIR
      ELBAZ

     

    THIS
      AGREEMENT
      made effective as of the 1st
      day of
      November, 2008, (“Effective Date”) by and between Dynamic Applications
      Corporation, a Delaware corporation with a principal place of business at46
      Techelet Street, Modiin, Israel 71700 (hereafter the "Company"),
      and
      Amir Elbaz, with a principal place of business at 147 East 82nd
      Street,
      New York, New York 10028 (hereafter the "Employee").

     

    RECITALS:

     

    WHEREAS,
      the
      Company is engaged in the business of developing, marketing, managing and
      operating proprietary technologies and intends to enter into new areas in the
      field of renewable power generation around the world (the
      "Business");

     

    WHEREAS,
      the
      Company desires to engage Employee to provide certain services related to the
      development and operation of the Business; and

     

    WHEREAS,
      Employee desires to render such services.

     

    NOW
      THEREFORE,
      in
      consideration of the mutual promises and covenants contained herein and other
      good and valuable consideration, the receipt and sufficiency of which are hereby
      acknowledged, the parties agree as follows: 

     

    1.     Employment.

     

         (a)     The
      Company hereby engages Employee as its President and Chief Executive Office
      who
      shall supervise and manage all aspects of the Company, and Employee hereby
      accepts the appointment to serve in each capacity at the Company. During the
      term of this Agreement, Employee will be responsible to report to the Board
      of
      Directors.

     

         (b)     Employee
      hereby accepts such appointment subject to the provisions and conditions of
      this
      Agreement. 

     

    2.
           Term
      of Agreement.
      

     

    The
      employment period shall begin upon the Effective Date and shall continue
      thereafter until the third (3rd) anniversary of the Effective Date (the
“Term”),
      unless
      sooner terminated pursuant to section 6 of this Agreement.

     

    The
      parties may agree by written amendment to continue this Agreement after that
      date on a year to year basis.

     

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

     

    3.
           Employee's
      Duties.
      Employee shall devote so much of his time and attention to the affairs of the
      Company. Employee shall perform the duties of President and Chief Executive
      Officer (the “Duties”).
      Nothing in this Agreement shall restrict Employee, however from expending his
      personal time on his own ventures or investments so long as: (i) such activities
      are consistent with Employee's Duties with the Company; (ii) such activities
      and
      time commitments do not impair the effective performance of his Duties for
      the
      Company; (iii) such activities do not, directly or indirectly, compete with
      the
      Business of the Company or violate his confidentially and intellectual property
      obligations; and (iv) Employee discloses to the Board of Directors any activity
      that may result conflict of interest with his duties. 

     

         (a)
           Employee will cooperate with the Company in any
      efforts by the Company to obtain a life insurance policy on the life of Employee
      for the benefit of the Company.

     

    4.
           Company's
      Duties.

     

         (a)
           The Company shall:

     

              (i)
           Compensate Employee as set forth in Section 5
      below. 

     

              (ii)
           Furnish the Employee with a suitable private
      office, and such equipment, supplies, instruments, and clerical and staff
      support as are reasonable and necessary to fulfil his Duties as set forth in
      this Agreement.

     

              (iii)
           Furnish Employee with such data, materials,
      documents and other information as are reasonable and necessary to fulfil his
      responsibilities and Duties as set forth in this Agreement.

     

              (iv)
           Reimburse Employee for all reasonable out of
      pocket business expenses he incurs to fulfil the terms of this Agreement,
      approved by the Company in accordance with its policies, rules, standards,
      and/or procedures governing such expenses, including without limitation, those
      for travel, lodging, food, telephone, facsimile and other electronic voice
      or
      data transmissions. Employee shall submit periodic reports of such expenses
      on
      forms with supporting documentation as the Company shall prescribe for its
      executive employees and the Company shall pay such reimbursement within
      forty-five (45) days of such submissions.

     

         (b)
           The Company, upon approval of the Board of
      Directors, may pay additional compensation to Employee as a member of management
      and/or for serving on the Board of Directors beyond that amount set forth in
      Section 5 below. The Board may approve such additional compensation if it views
      such additional compensation to be in the best interest of, and fair to the
      Company. Such additional compensation may be in the form of, without limitation,
      stock options, warrants, or performance bonuses.

     

    5.
           Compensation.
      

     

         (a)
           The Company shall pay Employee, at a minimum, a
      base annual salary of $180,000 ("Base
      Compensation")
      for
      each of the three (3) years during the Term of this Agreement. Compensation
      shall be in monthly instalment payable on the last day of each month, except
      as
      the parties may agree to another installment practice with the consent of the
      Board of Directors from time to time. There shall be no adjustment for cost
      of
      living increases or Consumer Price Index increases. This compensation is subject
      to Section 5(d) below. Notwithstanding the above, the Compensation for the
      initial two months of the Term shall be deferred and be paid on or before
      January 30th,
      2009.

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    (b)
           On or before January 7th,
      2009
      the Company shall issue Employee with two million two hundred thousand
      (2,200,000) shares of common stock of the Company (“Employee’s
      Shares”).
      The
      purchase price of the Employee’s Shares shall be $0.01 per share of common
      stock. 

     

    (c)
           On or before January 7th,
      2009
      the Company shall issue Employee with one million one hundred (1,100,000)
      thousand options to purchase shares of common stock of the Company
      (“Employee’s
      Options”).
      Two
      hundred seventy five thousand (275,000) of Employee’s Option shall be vested
      starting the first anniversary of this Agreement and continue for three
      subsequent anniversaries thereafter, subject to the Employee's continued
      employment on the end of each anniversary. The exercise price of the Employee’s
      Options shall be $0.01 per share of common stock. In the event of termination
      of
      Employee’s employment with the Company for any reason, excluding termination for
      Cause; all Employee’s Options shall be immediately vested in full and
      exercisable as of the date of termination of the employment. A notice of
      termination of employment shall be deemed to constitute termination of
      employment.
      The
      Employee’s Options may be exercised within a period of ninety (90) days after
      the date of such termination. 

     

    (d)
           On or before February 1st,
      2009
      the Company shall issue Employee with one million one hundred (1,100,000)
      thousand options to purchase shares of common stock of the Company
      (“Employee’s
      Performance Options”).
      Two
      hundred seventy five thousand (275,000) of Employee’s Option shall be vested
      starting the first anniversary of this Agreement and continue for three
      subsequent anniversaries thereafter, subject to the Employee's continued
      employment on the end of each anniversary. The exercise price of the Employee’s
      Options shall be $1.00 per share of common stock. In the event of termination
      of
      Employee’s employment with the Company for any reason, excluding termination for
      Cause; all Employee’s Performance Options shall be immediately vested in full
      and exercisable as of the date of termination of the employment. A notice of
      termination of employment shall be deemed to constitute termination of
      employment. The Employee’s Performance Options may be exercised within a period
      of ninety (90) days after the date of such termination.

     

    In
      the
      event of change of control of the Company during the Employee’s employment with
      the Company, all Employee’s Options and Employee’s Performance Options shall
      accelerate and become vested in full and exercisable as of the date of singing
      a
      Definitive Agreement for the acquisition of the Company by a third party (i.e.,
      sale of more than 51% of shares of Company to a third party who is not a
      Company’s stockholder of record as constituted immediately prior to such
      acquisition).

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

     

         (e)
           Employee shall be eligible to participate in
      coverage under the Company's employee and insurance plans or programs and other
      employee benefit plan or programs, if any, at least equal to the coverage
      provided to other full-time executives of the Company. In the event such
      coverage is not available, the Company shall compensate employee for COBRA
      payment made by employee for him and his immediate family. 

     

         (f)
           Employee may be paid additional compensation (as a
      member of management and/or the Board of Directors) as the Board may approve
      from time to time pursuant to Section 4(b) above.

     

         (g)
           If requested by Employee, Employee shall be
      provided with a Company car on a full time basis to meet his commuting needs.
      All associated costs including but not limited to parking, gas, tolls and
      insurance shall be covered by the Company. 

     

    6.     Termination.
      

     

         (
      6.1
      Early Termination.

     

    	(a)  	
            During
              the Term of this Agreement, the Company may terminate the Employ’s
              employment without Cause as defined below for any reason with the consent
              of the majority of the Company's Board of Directors by giving him thirty
              (30) day advance written notice (“Company Notice Period”). If the Company
              terminates the Employee during the Term without Cause he will be provided
              with special one lump severance payment equal to 6 month salary
              installments in addition to what he is entitled under section 5 hereof.
              

          

     

    	6.2  	
            Termination
              by the Company for “Cause.” 

          

     

    	(b)  	
            The
              Company may terminate the Employee employment for Cause thirty (30)
              days
              after the date on which the Employee shall have received written notice
              from the Board of Directors of the Company that it has decided to
              terminate his employment for Cause, which notice shall specify the
              nature
              of such Cause. 

          

     

    	(c)  	
            For
              all purposes under this Agreement “Cause”
              shall mean: (i) the failure of the Employee to diligently perform his
              duties to the Company, after having been provided written notice and
              30
              days to cure such failure; (ii) the engaging by the Employee in willful,
              reckless or negligent misconduct which is determined by the Board of
              Directors to be materially injurious to the Company or any of its
              affiliates (monetarily or otherwise); (iii) the Employee pleading guilty
              or no contest to, or conviction of, any felonious crime; (iv) the
              Employee’s fraudulent misappropriation, embezzlement or willful and
              material damage of or to any property of the Company; or (v) conduct
              by
              Employee constituting a breach of any statutory or judicially imposed
              fiduciary duty of care or loyalty to the Company
              .

          

     

    	(d)  	
            No
              severance payments will be paid to the Employee under this Agreement
              on
              account of a termination for Cause.

          

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

     

    	(e)  	
            6.3Resignation

          

     

    	(f)  	
            The
              Employee may terminate his employment by giving the Company ninety
              (90)
              day advance written notice.

          

     

    Disability
      or Death 

     

    	(g)  	
            In
              the event that Employee is unable for a period of one hundred eighty
              (180)
              consecutive days to substantially perform his Duties under this Agreement
              by reason of illness or incapacity during the Term of this Agreement.
              The
              Company may terminate his employment because of such disability with
              30
              days notice. In such termination the Employee will be provided with
              a
              special one lump severance payment equal to 6 month salary installments.
              

          

     

    	(h)  	
            In
              the event of the death of the Employee during the Term, the Employment
              shall terminate on the date of death and the Employee's designated
              beneficiary or, if none, his estate shall be entitled to receive (i)
              any
              accrued and unpaid Base Compensation, and Benefits through such date
              of
              death and (ii) continued monthly installments for six months following
              the
              date of death

          

     

    7.
      Confidentiality
      and Intellectual Property Agreement.
      

     

    (a)
      As a
      condition precedent to the entering into effect of this Agreement, the Employee
      shall execute the Confidentiality, and Intellectual Property Assignment
      Agreement attached hereto as Exhibit
      A,
      and any
      replacement assignment agreement as may be proposed by the Company from time
      to
      time. 

     

    	(b)  	
            The
              confidentiality provisions of Exhibit A are intended to supplement
              and not
              supersede the applicable provisions of the Uniform Trade Secrets Act,
              to
              the fullest extent applicable.

          

     

    8.
           Restrictive
      Covenants.

     

         (a)
           For a period of one (1) year after the expiration
      or termination of this Agreement for any reason whatsoever, Employee shall
      not,
      directly or indirectly, engage in activities for, nor render services (similar
      or reasonably related to those in which Employee shall have rendered to the
      Company) to, any person, entity, firm, business organization which directly
      or
      indirectly competes with the Business of the Company to the extent and insofar
      as such competition is based on or exploits the Confidential Information or
      Inventions (defined below) of the Company, whether now existing or hereafter
      established, nor shall Employee entice, induce or encourage any of the Company's
      employees to engage in any activity which, were it done by Employee, would
      violate any provision of this section.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

         (b)
           For a period of one (1) year after the expiration
      or termination of this Agreement for any reason whatsoever, Employee shall
      not,
      directly or indirectly, solicit the Company's employees or independent
      contractors to leave their employ or terminate their contracts with the Company.
      

     

                  Upon
      Employee's written request to the Company specifying the activities proposed
      to
      be conducted by Employee, the Company may in its discretion give Employee
      written approval(s) to personally engage in any activity or render services
      referred to in Subsection (a) upon receipt of written assurances (satisfactory
      to the Company and its counsel) from Employee and from Employee's prospective
      employer(s), partner(s) or company that the integrity and provisions of this
      Section will not in any way be jeopardized or violated by such activities,
      provided the burden of so establishing the foregoing to the satisfaction of
      the
      Company and its counsel shall be upon Employee and his prospective employer(s),
      partner(s) or company

     

         (c)
           The parties acknowledge that they have attempted
      to limit Employee's right to compete only to the extent necessary to protect
      the
      Company from unfair competition. However, the parties hereby agree that, if
      the
      scope or enforceability of the restrictive covenant is in any way disputed
      at
      any time, a court or other competent trier of fact may modify and enforce the
      covenant to the extent that it finds the covenant to be reasonable under the
      circumstances existing at the time.

     

         (d)
           Employee further acknowledges that: (1) in the
      event this Agreement with the Company terminates for any reason, he will be
      able
      to earn a livelihood without violating the foregoing restrictions; and (2)
      that
      his ability to earn a livelihood without violating such restrictions is a
      material condition to his retention by the Company.

     

         (e)
           Employee's duties under this Section 8 shall
      survive termination of this Agreement, however, Employee's duties under this
      Section 8 shall not survive termination of this Agreement without Cause as
      defined herein in section 6 (iii) (F). recommended to delete Employee
      acknowledges that a remedy at law for any breach or threatened breach by
      Employee of this Section 8 may be inadequate, and Employee therefore agrees
      that
      the Company shall be entitled to all available remedies in law including
      injunctive relief in case of any such breach or threatened breach.

     

    9.
           Warranty
      Against Prior Existing Restriction.
      Employee represents and warrants to the Company that he is not a party to any
      agreement containing a non-competition clause or other restriction with respect
      to: (a) the services which he is required to perform hereunder; or (b) the
      use
      or disclosure of any information directly or indirectly related to the Company's
      business, or to the services he is required to render pursuant
      hereto.

     

    10.     Severability.
      It is
      the desire and intent of the parties hereto that the provisions of this
      Agreement and its exhibit shall be enforced to the fullest extent permissible
      under the laws and public policy of each jurisdiction in which enforcement
      is
      sought. Accordingly, if any particular provision, section, or subsection of
      this
      Agreement or its exhibit is adjudged by any court of law to be void or
      unenforceable, in whole or in part, such adjudication shall not be deemed to
      affect the validity of the remainder of the Agreement, including any other
      provision, section, or subsection. In addition, if any one or more of the
      provisions contained in this Agreement or its exhibit shall for any reason
      be
      held to be excessively broad as to duration, geographical scope, activity or
      subject, it shall be construed by limiting and reducing it, so as to be
      enforceable to the extent compatible with the applicable law as it shall then
      appear. Each provision, section, and subsection of this Agreement and its
      exhibit is declared to be separable from every other provision, section, and
      subsection and constitutes a separate and distinct covenant.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    12.     Entire
      Agreement.
      This
      Agreement and its exhibit contain the entire understanding of the parties and
      supersede all previous verbal and written agreements. There are no other
      agreements, representations, or warranties not set forth herein.

     

    13.     Notices.
      All
      notices or other documents under this Agreement shall be in writing and
      delivered personally or mailed by certified mail, return receipt requested
      postage prepaid, addressed to the Company or Employee at their last known
      addresses. Addresses are as follows:

     

    If
      to the
      Company: 46
      Techelet Street

    Modiin,
      Israel 71700

    Attention:
      Chairman of the Board of Directors 

    

    With
      Copy
      to:  PEARL
      COHEN ZEDEK LATZER LLP

    1500
      Broadway, 12th Floor

    New
      York,
      NY10036

    Attention:
      Doron Latzer, Esq.

    

    If
      to
      Employee: Amir
      Elbaz

    147
      East
      82nd
      Street

    New
      York,
      NY 10028

     

    14.     Non-waiver.
      No
      delay or failure by either party to exercise any right under this Agreement,
      and
      no partial or single exercise of that right, shall constitute a waiver of that
      or any other right, unless otherwise expressly provided herein. 

     

    15.     Headings.
      Headings in this Agreement are for convenience only and shall not be used to
      interpret or construe its provisions.

     

    16.     Governing
      Law.
      This
      Agreement and its exhibit shall be construed in accordance with and governed
      by
      the laws of the State of New York.

     

    17.     Counterparts.
      This
      Agreement may be executed in two or more counterparts, each of which shall
      be
      deemed an original but all of which together shall constitute one and the same
      instrument.

     

    18.     Binding
      Effect.
      The
      provisions of this Agreement and its exhibit shall be binding upon and inure
      to
      the benefit of each of the parties and their respective successors and
      assigns.

     

    19.     Remedies.
      The
      parties agree that in addition to any other rights and remedies available to
      the
      Company for any breach by Employee of his obligations hereunder, the Company
      shall be entitled to enforce Employee's obligations hereunder by court
      injunction, or court ordered affirmative action, which injunction or ordered
      action may restrain a future breaking of this Agreement if there is reasonable
      ground to believe that such a breach is threatened. Employee further agrees
      to
      allow the Company to enjoin future use or disclosure of its Confidential
      Information if it has reasonable grounds to believe such action is necessary
      to
      protect such Confidential Information.

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    20.     Attorney's
      Fees.
      If
      either party hereto shall breach any of the terms hereof, such breaching party
      shall pay to the non-defaulting party all of the non-defaulting party's costs
      and expenses, including reasonable attorney's fees and costs, incurred by such
      party in enforcing the terms of this Agreement.

     

    21.     Prohibition
      Against Assignment.
      Employee agrees, for himself and on behalf of his successors, heirs, executors,
      administrators, and any person or persons claiming under him by virtue hereof,
      that this Agreement and the rights, interests, and benefits hereunder cannot
      be
      assigned, transferred, pledged, or hypothecated in any way and shall not be
      subject to execution, attachment, or similar process. Any such attempt to do
      so,
      contrary to the terms hereof, shall be null and void and shall relieve the
      Company of any and all obligations or liability hereunder.

     

     

    IN
      WITNESS WHEREOF,
      the
      Parties have duly executed this Agreement as of the date first written
      above.

     

    
      	 	 	 	For
              Company:
	 	 	 	 
	 	 	 	/s/
              Eyal Rosenberg
	
            	 	 	
              

            
	 	 	 	
              By:
                Eyal Rosenberg

              Its:
                Chairman of the Board of
                Directors

            

    

     

    
      	
            	 	 	For
              Employee:
	 	 	 	 
	 	 	 	/s/
              Amir Elbaz
	
            	 	 	
              

            
	 	 	 	
              By:
                Amir Elbaz

              As:
                Individual

            

    

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

       

    

    Exhibit
      A

     

    Confidentiality,
      and Intellectual Property Assignment 

    

    My
      obligations under this Confidentiality and Intellectual Property Assignment
      Agreement (hereafter “Agreement”)
      are
      toward (i) Dynamic Applications Corporation (the “Company”),
      and
      (ii) its present and future parent companies, subsidiaries, affiliates and
      successors. All of the aforementioned entities shall be referred to collectively
      as the “Company’s
      Entities”.

     

    	1.  	
            Confidentiality

          

     

    	1.1.  	
            I
              will regard and retain as confidential and will not divulge to any
              third
              party, or use for any unauthorized purposes either during or after
              the
              term of my employment with the Company, any proprietary or confidential
              information or know-how, as defined below (collectively “Confidential
              Information”),
              that I may have acquired during my service or in connection with my
              employment or contacts with the Company’s Entities, without the written
              consent of an authorized representative of the
              Company.

          

     

    	1.2.  	
            Confidential
              Information
              shall include, but will not be limited to, information regarding research
              and development related to actual or anticipated products, inventions,
              whether patentable or non-patentable, hardware, software or other
              products, methods of manufacture, trade secrets, test results, processes
              data, know-how, improvements, intension, ideas, techniques, business
              plans, business and financial activities, customer lists, finances,
              banking, investments, investors, properties, employees, marketing plans
              and any other data related to the business or affairs of the Company's
              Entities. Confidential Information will include information in written,
              oral or any other form of communication. Confidential information shall
              not include, however, any information that is: (i) known to me at the
              time
              I commenced employment with the Company as shown by evidence, (ii)
              publicly known or becomes publicly known through no act or fault on
              my
              part, (iii) disclosed to me by third parties who are not subject to
              confidentiality undertakings toward the Company’s Entities through no act
              or fault on my part; or (iv) required to be disclosed by law or pursuant
              to a judicial order or similar decree.

          

     

    	2.  	
            Return
              of Confidential Information 

          

     

    All
      materials including, but not limited to, documents, notes, memoranda, records,
      diagrams, blueprints, bulletins, formulas, reports, computer programs, and
      any
      other material of any kind and in any form, coming into my possession or
      prepared by me in connection with my service, are the exclusive property of
      the
      Company (hereinafter the "Documents").
      I
      agree to return to the Company all such Documents upon termination of my
      employment, unless I acquire the Company’s specific written consent to release
      any such Document.

     

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

     

    	3.  	
            Ownership
              Rights

          

     

    Without
      additional compensation and consideration, I hereby assign and will in the
      future assign to the Company, and acknowledge and will in the future acknowledge
      the Company’s exclusive right, (including any ‘moral’ right) domestic and
      foreign, to any and all intellectual property, including, without limitations,
      all inventions, improvements, mask works, discoveries, or works, either capable
      of being patented or copyrighted or not, which I may conceive, make, develop,
      author, or work on, in whole or in part, independently, or jointly with others,
      during the term of my employment with the Company, which are either (i) related
      to the Company’s Entities’ business or actual or demonstrably anticipated
      research or development; (ii) resulting directly or indirectly from any work
      I
      performed for the Company; or (iii) developed in whole or in part on the
      Company’s time or with the use of any Company’s equipment, supplies, facilities,
      or trade secret (hereinafter the “Company’s Entities’ Intellectual
      Property”).

    

    	4.  	
            Disclosure
              and Assignment of Inventions

          

     

    I
      will
      promptly disclose and describe to the Company all of the Inventions which I
      may
      conceive, make, reduce to practice, develop, author, or work on, in whole or
      in
      part, independently, or jointly with others, during the period of my service
      with the Company, which either; (i) relate to the Company’s Entities’ business
      or actual or demonstrably anticipated research or development, (ii) are
      developed in whole or in part on the Company's time or with the use of any
      of
      the Company's equipment, supplies, facilities or trade secret information,
      or
      (iii) results directly or indirectly from any work I performed for the Company
      (hereinafter the "Inventions").
      I
      agree to assign and do hereby assign to the Company any right, title and
      interest I might have worldwide in such Inventions and any intellectual property
      right based upon such Inventions. 

    

    	5.  	
            Employee
              Assistance

          

     

    I
      will,
      at the Company’s expense, assist in preparation and registration of patents and
      any other intellectual property right in favor of the Company, in any
      jurisdiction deemed appropriate by the Company. Such assistance shall include,
      without limitation, the preparation of documents, drawings and other data and
      execution of assignments, applications and other forms. I agree to perform
      this
      obligation during and after my service with the Company. In order to give full
      effect to this section I hereby irrevocably appoint the Company (and its
      representatives) as my attorney in fact, authorized in my name and on my behalf
      to execute all such documents.

     

    	6.  	
            No
              Conflicting Obligations

          

     

    I
      will
      not disclose to the Company any proprietary or confidential information
      belonging to any third party, including any prior or current employer or
      contractor, unless I have first received the written approval of that third
      party and present it to the Company. I undertake not to perform any activity
      related to my employment with the Company on the premises of any third party,
      or
      while using any equipment or materials that belong to any such third party,
      unless instructed to do so by the Company.

    

    	7.  	
            Third
              Party Information

          

     

    I
      recognize that the Company has received and will in the future receive from
      third parties their confidential or proprietary information, subject to a duty
      on the Company’s part to maintain the confidentiality of such information and to
      use it only for certain limited purposes. I agree to hold all such confidential
      or proprietary information in the strictest confidence and not to disclose
      it to
      any person or entity or to use it except as necessary in carrying out my
      services for the Company, consistent with the Company’s agreement with such
      third party.

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

     

    	8.  	
            Breach
              of Obligation

          

     

    I
      agree
      that, in the event of any breach of any provision hereof, the Company may or
      will not have an adequate remedy in money or damages. I therefore agree that,
      in
      such event, the Company shall be entitled to obtain injunctive relief against
      such breach in any court of competent jurisdiction, without the necessity of
      posting a bond even if otherwise normally required. Such injunctive relief
      will
      in no way limit the Company’s right to obtain other remedies available under
      applicable law. No failure or delay by a party hereto in enforcing any right,
      power or privilege created hereunder shall operate as an implied waiver thereof,
      nor shall any single or partial enforcement thereof preclude any other or
      further enforcement thereof or the enforcement of any other right, power or
      privilege. Without derogation from the above and from Company’s right to take
      any legal means, I agree to indemnify and hold harmless Company against any
      claim, cost and/or expense that it may endure as a result of any breach of
      any
      provision hereof.

    

    	9.  	
            Assignment

          

     

    This
      Agreement may be assigned by the Company. I may not assign or delegate my
      obligations under this Agreement, without the Company's prior written approval.
      

    

    	10.  	
            Condition
              to Employment

          

     

    I
      acknowledge that execution of this Agreement is a condition to the Company's
      engagement with me and the disclosure of any Confidential Information.

     

    In
      witness hereof, the parties hereto have executed this Agreement the day and
      year
      first above written. 

    

    Dynamic
      Applications Corporation    Amir
      Elbaz 

    

    By: ____________________________  ____________________________

    Title:
       ____________________________  

    Date: ____________________________  Date:________________________

     

    
      
         

      

      
        11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00149-of-00352.parquet"}]]